Results 121 to 130 of about 731 (176)

Cancer Patient Perspectives on Clinical Trial Discussion and Informed Consent Through Telemedicine. [PDF]

JCO Oncol Pract
Khadem Charvadeh Y, Doshi SD, Seier K, Bange EM, Daly B, Lipitz-Snyderman A, Polubriaginof FCG, Buckley M, Kuperman G, Stetson PD, Schrag D, Morris MJ, Panageas KS.   +12 more
europepmc   +1 more source

Leveraging natural language processing to aggregate field safety notices of medical devices across the EU. [PDF]

NPJ Digit Med
Ren Y, Caiani EG.
europepmc   +1 more source

Immune Spatial Organization Predicts Distant Metastasis Risk in Aggressive Localized Prostate Cancer. [PDF]

Clin Cancer Res
Yang DD, Abdelnaser A, Haas AJ, Wala J, Barney AA, Saad E, Crowdis JP, Ricker CA, Awad S, Gurel B, Park J, King MT, Nguyen PL, Choueiri TK, Einstein DJ, Balk SP, Tewari AK, de Bono JS, Salari K, Taplin ME, Wu CL, Van Allen EM.   +21 more
europepmc   +1 more source

Functionally high-risk disease is associated with poor outcomes after late-line CAR T-cell therapy for multiple myeloma. [PDF]

Blood Cancer J
Hashmi H, Sebastian T, Rajeeve S, Farzana T, Firestone RS, Jurgens EM, Miller KC, Maura F, Lesokhin AM, Tan CR, Shah GL, Korde N, Landau HJ, Merz M, Scordo M, Hassoun H, Maclachlan KH, Shah UA, Hultcrantz ML, Derkach A, Nemirovsky D, Giralt S, Mailankody S, Usmani SZ.   +23 more
europepmc   +1 more source

Brief Report: Safety of Pulse-Dose Osimertinib for Treatment of Leptomeningeal Disease or Refractory Brain Metastases in EGFR-Mutated Nonsmall Cell Lung Cancer. [PDF]

Clin Lung Cancer
Sun F, Nagpal S, Singhal S, Neal JW, Wakelee HA, Myall NJ, Bolan P, Riess JW, Gandara DR, Das MS.   +9 more
europepmc   +1 more source

Cladribine, idarubicin, and cytarabine (CLIA) for patients with relapsed and/or refractory acute myeloid leukemia: A single-center, single-arm, phase 2 trial. [PDF]

Cancer
Goulart H, Kantarjian H, Borthakur G, Daver N, DiNardo CD, Jabbour E, Pemmaraju N, Alvarado Y, Atluri H, Yilmaz M, Haddad FG, Marx KR, Rausch C, Loghavi S, Jain N, Garcia-Manero G, Ravandi-Kashani F, Kadia TM.   +17 more
europepmc   +1 more source

A Mitochondrial Plasma Proteomic Signature Identifies Metastatic Chromophobe Renal Cell Carcinoma. [PDF]

Cancers (Basel)
Steiner C, Han T, Safi S, Bzeih W, Mansour H, Saad E, Williams JF, Hirsch MS, Giri VK, Ascione L, Elon Y, Dicker AP, Tang Y, Choueiri TK, Henske EP, Xu W.   +15 more
europepmc   +1 more source

Cytomegalovirus reactivation during treatment with bispecific antibodies for relapsed/refractory multiple myeloma. [PDF]

Blood Cancer J
Jurgens E, Shekarkhand T, Rueda C, Nemirovsky D, Derkach A, Firestone RS, Miller K, Costa BA, Rajeeve S, Lesokhin AM, Korde N, Tan CR, Hashmi H, Hassoun H, Maclachlan K, Shah UA, Hultcrantz M, Hamadeh I, Giralt SA, Shah GL, Landau HJ, Scordo M, Usmani SZ, Mailankody S, Shahid Z.   +24 more
europepmc   +1 more source

An assessment of time toxicity in patients receiving [177Lu]Lu-PSMA-617 for metastatic castration-resistant prostate cancer. [PDF]

Oncologist
Scharf Z, Muniz M, Tchitchkan E, Rami A, Ravi P, Orme JJ, Tarhini A, Jacene HA, Sentana-Lledo D, Childs DS.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Autocompletion for mashups

Proceedings of the VLDB Endowment, 2009
A mashup is a Web application that integrates data, computation and UI elements provided by several components into a single tool. The concept originated from the understanding that there is an increasing number of applications available on the Web and a growing need to combine them in order to meet user ...
Ohad Greenshpan, Tova Milo, Neoklis Polyzotis   +2 more
openaire   +2 more sources